About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

DermAI to Evaluate Human Factor of Testing | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT06387472

DermAI to Evaluate Human Factor of Testing

The purpose of this research is to improve how well remote patch allergy testing works and make sure they are easy and practical for people to use from home.

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Mayo Clinic

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•\- Willing and able to provide informed consent.

Exclusion Criteria

•Has used topical or oral steroids two weeks prior to patch testing.
•Currently taking immunosuppression agents or is immunocompromised due to medical condition.
•No sunburn or rash at site of testing.
•Women who are breastfeeding or pregnant.
•Treatment with ultraviolet (UV) light (including tanning) during the two weeks prior to visit.
•Subjects unable to comply with patch test study requirements including multiple return visits and activity restrictions (e.g., protecting patch test area from excess moisture due to showering).

Related studies

Enrolling By InvitationNA

Rate of Allergic Contact Dermatitis and Cosmetic Outcomes

NCT06957444 · Allergic Contact Dermatitis, Osteoarthritis, Hip, and more

Active Not Recruiting

Methotrexat to Hand Eczema in the BIOSKIN Cohort

NCT07338305 · Atopic Dermatitis, Contact Dermatitis, and more

COMPLETEDPhase 3

The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis

NCT05498467 · Allergic Contact Dermatitis

EpiCeram for Skin Protection in Healthcare Workers

NCT04793711 · Irritant Contact Dermatitis

Not Yet Recruiting

Characterization of Visual Characteristics in Allergic Contact Dermatitis Using the Skincam® Tool

NCT06351449 · Allergic Contact Dermatitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 10, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment151

Start dateMay 2024

Last updatedSep 10, 2025

Condition

Contact Dermatitis

Locations shown

Mayo Clinic in Florida

Jacksonville, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 10, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions